Spirepoint Private Client Portfolio holdings
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$33.3M |
| 2 |
Apple
AAPL
|
+$4.34M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$3.46M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$3.28M |
| 5 |
Vanguard Total Bond Market
BND
|
+$2.93M |
Top Sells
| 1 |
Cigna
CI
|
+$7.46M |
| 2 |
Procter & Gamble
PG
|
+$5.89M |
| 3 |
Home Depot
HD
|
+$5.52M |
| 4 |
Rivian
RIVN
|
+$4.73M |
| 5 |
Sprouts Farmers Market
SFM
|
+$4.31M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Industrials | 18.79% |
| 3 | Healthcare | 8.46% |
| 4 | Financials | 7.86% |
| 5 | Consumer Discretionary | 7.65% |
Similar funds
Spirepoint Private Client's Q4 2025 Portfolio in Review
As of Q4 2025, Spirepoint Private Client held 325 positions worth $1.05B, up 10% from $951M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Spirepoint Private Client deployed $67.6M of net new capital in Q4 2025, opening 45 new positions and adding to 175 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 2,925 shares worth $620K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Cigna, an estimated $7.46M trimmed.
- Spirepoint Private Client's largest Q4 2025 buy was iShares S&P 500 Value ETF: 2,925 shares worth $620K.
- Spirepoint Private Client added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $33.3M increase.
- Spirepoint Private Client's biggest Q4 2025 reduction was Cigna, cutting an estimated $7.46M.
- Spirepoint Private Client fully exited Sprouts Farmers Market in Q4 2025, selling an estimated $4.31M.
- Spirepoint Private Client's ten largest holdings make up 39% of its $1.05B portfolio in Q4 2025.
- Spirepoint Private Client opened 45 new positions and closed 12 in Q4 2025.
- Spirepoint Private Client's portfolio value rose 10% quarter-over-quarter to $1.05B.
Based on Spirepoint Private Client's 13F filing for Q4 2025, filed 22 Jan 2026.